Exscientia stock.

Nov 2, 2023 · Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective ...

Exscientia stock. Things To Know About Exscientia stock.

The stock with a short interest of ~14% has added more than 92% this month, ... Exscientia (NASDAQ:EXAI), another AI-driven pharma tech company, has gained more than 36% this month.Legal Name Exscientia Ltd. Stock Symbol NASDAQ:EXAI. Company Type For Profit. Contact Email [email protected]. Phone Number +44-1865-818941. Exscientia is applying AI and big data processing to accelerate drug discovery and development. At the forefront of small molecule drug discovery. They are the first company to automate drug …The company also recognized $1.5 million in net foreign exchange losses. Exscientia's stock showed mixed momentum, with a one-year decline of 24.04%, but positive growth over 3, 6, and 9 months.Stocks to watch include Exscientia’s rivals in AI-led drug discovery including Recursion Pharmaceuticals , Abcellera Biologics , Absci Corporation and Schrodinger . The multi-year partnership ...Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023. 07/18/2023.

May 26, 2023 · Shares of Exscientia ... The artificial intelligence (AI)-driven precision medicine biotech stock is up more than 47% so far this year. It closed last week at $6.04 a share, then rose to as high ... Nov 6, 2023 · Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 2.78% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.10 and a low of $5.15. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ...

Can Exscientia Stock Earn a Higher Valuation? ... Exscientia held $720 million in cash, had 33 active programs, and 12 drug development collaborations at the end of March 2022.

EXAI Exscientia plc Stock Price & Overview $6.12 0.02 ( +0.33%) 2:54 PM 12/01/23 NASDAQ | $USD | Realtime Summary Ratings Financials Earnings Dividends …Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI …The share price of Exscientia plc (EXAI) now. What analysts predict: $9.5. 52-week High/Low: $11.52 / $4.09. 50/200 Day Moving Average: $5.22 / $6.25. This figure corresponds to the Average Price over the previous 50/200 days. For Exscientia stocks, the 50-day moving average is the support level today. For Exscientia stocks, the 200 …Comparatively, Exscientia has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Summary Valneva beats Exscientia on 10 of the 17 factors compared between the two stocks.

Get the latest information on Exscientia PLC ADR (EXAI), a biotechnology company that uses AI to design novel drug candidates. See the stock price, news, valuation, dividends, sustainability and more from Morningstar.

Exscientia PLC Sponsored ADR (EXAI) closed the last trading session at $6.10, gaining 10.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...

Of course Exscientia may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.Shares of Exscientia PLC Sponsored ADR (EXAI) have gained 7.6% over the past four weeks to close the last trading session at $5.40, but there could still be a solid upside left in the stock if ...Stock Information · Quote · Charts · Historical Data · Corporate Governance · Governance Documents · Management Team · Board of Directors · Board Committees.Is Exscientia PLC (EXAI) a Stock to Watch After Gaining 4.96% This Week? InvestorsObserver - Oct 25, 2023, 10:22AM Phio Pharmaceuticals, Exscientia among …OXFORD, England-- (BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) will report financial results for the second quarter ended June 30, 2023, on Thursday August 10, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to provide a business update and review …

Stocks / United States / Pharmaceuticals & Biotech Exscientia NasdaqGS:EXAI Stock Report Last Price US$6.10 Market Cap US$762.1m 7D 12.8% …Exscientia PLC Sponsored ADR (EXAI) Stock Jumps 13.5%: Will It Continue to Soar? finance.yahoo.com - October 12 at 9:54 AM: Exscientia plc (NASDAQ:EXAI) most popular amongst individual investors who own 58% of the shares, institutions hold 27% finance.yahoo.com - October 11 at 8:42 AMExscientia Stock Forecast 11-28-2023. Forecast target price for 11-28-2023: $ 6.01. Negative dynamics for Exscientia shares will prevail with possible volatility of 5.710%. Pessimistic target level: 5.81.If a therapeutic is commercialized, Exscientia will receive tiered royalties on product sales. The stock has lost 5.1% year to date through Tuesday, while the S&P 500 has gained 15.7%. -Tomi KilgoreJul 12, 2023 · Shares of Exscientia (EXAI 2.18%) ... The stock is up more than 38% so far this year. So what. Exscienta is an AI-driven precision medicine company that focuses on oncology therapies. The clinical ... Overview | EXAI U.S.: Nasdaq Exscientia PLC ADR Watch NEW Set a price target alert Premarket Last Updated: Nov 30, 2023 5:47 a.m. EST Delayed quote $ 6.01 0.01 0.17% Before Hours Volume: 87... Legal Name Exscientia Ltd. Stock Symbol NASDAQ:EXAI. Company Type For Profit. Contact Email [email protected]. Phone Number +44-1865-818941. Exscientia …

Jul 11, 2023 · The Schrödinger Building Oxford Science Park, Oxford OX4 4GE . Phone: +44 (0) 1865 818941 Nov 29, 2023 · Stock analysis for Exscientia Plc (EXAI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Nov 17, 2023 · The latest Exscientia stock prices, stock quotes, news, and EXAI history to help you invest and trade smarter. Last but not least, Exscientia's AI-driven drug discovery platform is able to anticipate the effectiveness of cancer therapy in the clinic, while also matching the drug with the most relevant patient group. AbCellera Biologics Inc (NASDAQ: ABCL) AbCellera is a Vancouver-based biotech company, which develops antibody therapeutics using AI.ExScientia Ltd Stock Earnings. The value each EXAI share was expected to gain vs. the value that each EXAI share actually gained. ExScientia Ltd ( EXAI) reported Q2 2022 earnings per share (EPS) of -$0.30, missing estimates of -$0.19 by 56.83%. In the same quarter last year, ExScientia Ltd 's earnings per share (EPS) was $0.Stocks / United States / Pharmaceuticals & Biotech Exscientia NasdaqGS:EXAI Stock Report Last Price US$6.10 Market Cap US$762.1m 7D 12.8% …Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently down 0.37% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.32 and a low of $4.95. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ...Portfolio news - Exscientia raises US$26 million in Series B funding round and announces AI drug discovery collaboration with Roche worth up to CHF 67 million ... This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider …

Company profile page for Exscientia Plc including stock price, company news, press releases, executives, board members, and contact information

Nov 29, 2023 · Stock analysis for Exscientia Plc (EXAI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

What is Exscientia's Market Cap? ( NASDAQ: EXAI) Exscientia 's market cap is $727.15M, as of Nov 24, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Exscientia 's market cap is calculated by multiplying EXAI 's current stock price of $5.84 by EXAI 's total …Dec 1, 2023 · View Exscientia PLC Sponsored ADR EXAI investment & stock information. Get the latest Exscientia PLC Sponsored ADR EXAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Jeremy Moeller/Getty Images. Only a day after Bristol Myers Squibb signed a licensing deal with Agenus with an upside potential of $1.56 billion, BMS inked a collaboration agreement with Exscientia, an Artificial Intelligence (AI)-focused biopharma company, that could hit $1.2 billion.. The collaboration will leverage AI to speed the …We are a creative, passionate and collaborative organisation dedicated to setting bold new standards in drug discovery and design. If you have the ingenuity, energy and ambition to help us change the world, we would love to hear from you. Open positions. At Exscientia, we combine the power of AI and human creativity to make safer and more ...Dec 1, 2023 · The Exscientia plc stock price gained 1.15% on the last trading day (Friday, 1st Dec 2023), rising from $6.10 to $6.17. During the last trading day the stock fluctuated 5.73% from a day low at $5.93 to a day high of $6.27. The price has been going up and down for this period, and there has been a 3.35% gain for the last 2 weeks. Exscientia Plc has an analyst consensus of Moderate Buy, with a price target consensus of $14.00. See the top stocks recommended by analysts >> EXAI market cap is currently $883.3M and has a P/E ...Exscientia’s total winnings from the Nasdaq initial public offering (IPO) and a private placement led by the tech-focused investor SoftBank were an impressive €442.1M ($510.4M). This took the company’s valuation to €2.5B ($2.9B). Was a great day on Friday. But just the end of a long beginning and I'm so excited and proud to be part of ...

Exscientia Stock Forecast 11-28-2023. Forecast target price for 11-28-2023: $ 6.01. Negative dynamics for Exscientia shares will prevail with possible volatility of 5.710%. Pessimistic target level: 5.81.EXAI: Exscientia Plc Stock Price Quote - NASDAQ GS - Bloomberg Bloomberg Connecting decision makers to a dynamic network of information, people and …Description. Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe and efficacious compounds for clinical ... Instagram:https://instagram. sahara desert marathondating website for smokersstock at 52 week lowmanulife shares May 24, 2023 · That made the stock quite an outlier, as the S&P 500 index slipped by 0.7% on the day. So what Exscientia, which harnesses AI in the discovery and development of pharmaceuticals, published its ... harborway insurance bbbsteel 1943 penny worth View the latest Exscientia PLC ADR (EXAI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 7.04% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.10 and a low of $5.15. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ... vanguard brokerage account fees 20 сент. 2023 г. ... Use of technology ... Exscientia PLC shares climbed as much as 30% in pre-market trading on Wednesday after the precision-medicine company ...Currently, the most bullish analyst values Exscientia at UK£13.35 per share, while the most bearish prices it at UK£9.43. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.Best-in-Class Portfolio Monitoring. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.